Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Acadia Pharmaceutica (ACAD)
Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,751,513
  • Shares Outstanding, K 164,180
  • Annual Sales, $ 517,240 K
  • Annual Income, $ -215,980 K
  • 60-Month Beta 0.59
  • Price/Sales 7.17
  • Price/Cash Flow N/A
  • Price/Book 10.24
Trade ACAD with:

Options Overview Details

View History
  • Implied Volatility 63.28% ( -4.71%)
  • Historical Volatility 34.90%
  • IV Percentile 84%
  • IV Rank 45.68%
  • IV High 111.29% on 12/27/22
  • IV Low 22.91% on 11/20/23
  • Put/Call Vol Ratio 1.36
  • Today's Volume 179
  • Volume Avg (30-Day) 1,172
  • Put/Call OI Ratio 1.83
  • Today's Open Interest 59,271
  • Open Int (30-Day) 64,617

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.33
  • Number of Estimates 10
  • High Estimate 0.59
  • Low Estimate 0.23
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +226.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.58 +3.85%
on 11/10/23
25.57 -12.36%
on 11/06/23
-1.66 (-6.90%)
since 11/03/23
3-Month
20.31 +10.37%
on 10/02/23
27.65 -18.94%
on 09/06/23
-5.16 (-18.72%)
since 09/05/23
52-Week
14.45 +55.09%
on 12/08/22
33.99 -34.07%
on 07/18/23
+7.17 (+47.05%)
since 12/05/22

Most Recent Stories

More News
Acadia: Q3 Earnings Snapshot

Acadia: Q3 Earnings Snapshot

ACAD : 22.51 (-1.49%)
Why Acadia Pharmaceuticals Stock Is Rising Today

An analyst upgrade is sparking a rally in the drugmaker's shares today.

JPM : 158.03 (+0.03%)
ACAD : 22.51 (-1.49%)
2 Growth Stocks I'd Buy on the Dip

These two growth stocks could be worthwhile buy-and-holds.

BUD : 63.40 (+0.40%)
ACAD : 22.51 (-1.49%)
TLRY : 1.89 (-8.50%)
Betting Big On Biotech: Six Undervalued Biotech Stocks To Keep On Your Radar

Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...

HALO : 40.22 (+0.27%)
KNSA : 17.20 (+0.82%)
ACAD : 22.51 (-1.49%)
HRMY : 32.71 (+4.67%)
AMPH : 57.89 (-3.39%)
INCY : 54.60 (-0.66%)
AGEN : 0.8039 (-3.49%)
NVS : 97.28 (-1.73%)
PFE : 29.15 (-0.44%)
SGEN : 214.86 (+0.81%)
MRK : 106.13 (+1.02%)
RXDX : 199.92 (+0.09%)
Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?

This biotech stock has been on fire in 2023.

ACAD : 22.51 (-1.49%)
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street

This small-cap biotech might be a hidden gem.

ACAD : 22.51 (-1.49%)
STOK : 4.26 (+1.43%)
Acadia: Q2 Earnings Snapshot

Acadia: Q2 Earnings Snapshot

ACAD : 22.51 (-1.49%)
Acadia Pharmaceuticals: A Mid-Cap Biotech Making Large Moves

Acadia may experience a profit-taking pullback near-term but the recent high volume gapper and promising pipeline developments bode well for long-term uptrend.

ACAD : 22.51 (-1.49%)
NURPF : 10.9000 (+9.33%)
UnitedHealth Group, Elanco rise; Leslie's, State Street fall, Friday, 7/14/2023

Stocks that traded heavily or had substantial price changes on Friday: UnitedHealth Group, Elanco rise; Leslie’s, State Street fall

JPM : 158.03 (+0.03%)
UNH : 551.20 (+0.53%)
ACAD : 22.51 (-1.49%)
ELAN : 12.86 (+0.23%)
STT : 73.52 (-0.78%)
UNTY : 28.01 (-0.50%)
OGI.TO : 1.83 (-6.15%)
Why Acadia Pharmaceuticals Stock Is Soaring Today

Investors are cheering Acadia's latest news.

NEU.AX : 15.660 (-2.79%)
ACAD : 22.51 (-1.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative medicines to address the unmet medical needs in central nervous system (CNS) disorders. The company's sole marketed drug Nuplazid (pimavanserin) is the first and the only FDA-approved treatment for hallucinations...

See More

Key Turning Points

3rd Resistance Point 23.77
2nd Resistance Point 23.42
1st Resistance Point 23.13
Last Price 22.51
1st Support Level 22.49
2nd Support Level 22.14
3rd Support Level 21.85

See More

52-Week High 33.99
Fibonacci 61.8% 26.53
Fibonacci 50% 24.22
Last Price 22.51
Fibonacci 38.2% 21.91
52-Week Low 14.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar